Alchip Technologies
Recognizes Asia leaders across multiple segments
Taipei, Taiwan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- For the second year in a row, Alchip Technologies is one of only 200 Asian companies named to Forbes Asia’s prestigious "Best Under a Billion."
The Forbes list features companies with a record of long-term sustainable performance across a variety of metrics. Those listed were selected from a universe of more than 20,000 publicly traded companies in the Asia-Pacific region.
"It is an unbelievable honor to be named to the 2024 list and it is breath taking to be included two years in a row," said Johnny Shen, Alchip CEO.
Alchip is one of 19 Taiwan companies named to the list and is the largest from the island nation with 2023 revenues listed $978 million.
Like all companies on the unranked Forbes list, Alchip was selected based on a composite score using measures such as debt, sales, and earnings-per-share growth over both the most recent fiscal one- and three-year periods, and the strongest one- and five-year average return on equity.
"Geopolitical and inflationary headwinds sapped momentum from some Asia-Pacific economies, but strong domestic demand, supported by an uptick in infrastructure spending and global trade, powered the region’s overall growth in 2023. Our annual Best Under a Billion list of 200 small and midsized publicly traded companies, with sales under $1 billion, bears testimony to that economic resilience," Forbes Asia editors said when announcing the list.
Aside from quantitative criteria, qualitative screens were applied as well, such as excluding companies with serious governance issues, questionable accounting practices, environmental concerns, management problems or legal troubles in recent years. State-controlled entities and subsidiaries of larger companies were also excluded. The criteria sought to ensure a geographical diversity of companies from across the region and used annual results based on the latest publicly available figures as of July 7, 2024.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Gatorade31.5.2025 17:39:49 CEST | Press release
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
F. Hoffmann-La Roche Ltd31.5.2025 14:05:00 CEST | Press release
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
Ipsen Pharma31.5.2025 14:00:00 CEST | Press release
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
WithSecure Oyj31.5.2025 08:45:00 CEST | Press release
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
Teva Pharmaceutical Industries Ltd31.5.2025 03:05:00 CEST | Press release
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom